Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Approval of the 2023 Omnibus Stock and Performance Compensation Plan
At the 2023 Annual Meeting of Shareholders (the "Annual Meeting") of
The 2023 Omnibus Plan permits the grant of stock options (incentive stock options and nonqualified stock options), stock appreciation rights, restricted stock, restricted stock units, phantom stock, and cash-based performance awards. The 2023 Omnibus Plan will be administered by the Compensation Committee of the Board or by its delegate.
A total of 1,000,000 shares of Common Stock,
The Board may terminate or amend the 2023 Omnibus Plan at any time; provided,
however, that amendment of the 2023 Omnibus Plan will be subject to shareholder
approval in certain circumstances. The 2023 Omnibus Plan will terminate on
This description of the 2023 Omnibus Plan is a summary only and is qualified by
reference to the 2023 Omnibus Plan, which is filed as Exhibit 10.1 hereto. A
more complete description of the terms of the 2023 Omnibus Plan can be found in
section IV, "Approval of the 2023 Omnibus Stock and Performance Compensation
Plan - Proposal 4" on pages 17 to 25 of the Company's definitive proxy statement
filed with the
Grant of Restricted Stock
As previously announced by the Company,
The terms of the restricted stock are as set forth in the relevant portions of the Company's form of Restricted Stock Agreement (the "Award Agreement"). Of the total shares awarded, 2,127 are time-based restricted stock that will cliff vest three years from the date of grant and 3,191 are performance-based restricted stock that will vest three years from the date of grant with amounts earned, if any, based on the Company's achievement of earnings per share and return on equity performance targets for the prospective three-year performance period. The ultimate number of performance-based shares earned will range from 0% to 150% of the target award based on the Company's achievement of these performance goals, with no performance-based awards being earned if threshold performance targets are not met. Vesting is accelerated, in certain circumstances, upon termination of employment in the event of death, disability or following a change of control, subject to the terms set forth in the Award Agreement. Time-based restricted stock carries voting and dividend rights from the date of grant; holders of performance-based restricted stock are entitled to voting and dividend rights only upon satisfaction of applicable performance criteria and vesting of the shares. In both cases, the payment of any dividends is deferred until the shares to which such dividends are attributable vest.
In the event that the Company materially restates its financial statements, the restricted stock shall be subject to rescission, revocation, adjustment, modification or otherwise in accordance with the Company's governing Clawback
2
--------------------------------------------------------------------------------
Policy, as it may be amended from time to time in compliance with the rules and
regulations of the
The summary of the terms of the restricted stock is qualified in its entirety by
reference to the terms set forth in the form of the Award Agreement, a copy of
which is filed as Exhibit 10.2 to this Current Report on Form 8-K and
incorporated herein by reference. Further information about the Company's
long-term incentive compensation program is discussed in the Company's most
recent definitive proxy statement on Schedule 14A, filed with the
Item 5.07. Submission of Matters to a Vote of Security Holders.
On
(a) Election of five directors to serve three-year terms ending in 2026, as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Eric H. Brunngraber 9,544,237 591,965 61,000 1,878,709 Benjamin F. Edwards, IV 9,788,369 345,889 62,944 1,878,709 Ann W. Marr 9,996,878 139,273 61,052 1,878,709 Martin H. Resch 9,948,866 188,571 59,765 1,878,709 Joseph D. Rupp 9,978,646 155,925 62,632 1,878,709
All director nominees were elected.
(b) Advisory approval of the Company's executive compensation:
Votes For Votes Against Abstentions Broker Non-Votes 9,900,410 203,377 93,415 1,878,709
The Company's executive compensation was approved by advisory vote.
(c) Advisory vote on the frequency of executive compensation advisory vote:
1 Year 2 Years 3 Years Abstentions Broker Non-Votes 9,322,698 9,015 787,427 78,062 1,878,709
By advisory vote, the shareholders voted to hold an advisory vote on executive compensation every year.
(d) Approval of the Company's 2023 Omnibus Plan:
Votes For Votes Against Abstentions Broker Non-Votes 9,788,611 318,396 90,195 1,878,709
The Company's 2023 Omnibus Plan was approved.
(e) Ratification of the selection ofKPMG LLP as the Company's independent registered public accounting firm for 2023: Votes For Votes Against Abstentions 11,930,125 111,424 34,362 3
--------------------------------------------------------------------------------
The selection of
Item 8.01. Other Events.
Also on
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description of Exhibit 10.1Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan 10.2 Form of Restricted Stock Award Agreement under theCass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
--------------------------------------------------------------------------------
© Edgar Online, source